Asia-Pacific Professional Acne Medication Market by Acne Type (Inflammatory Acne and Non-inflammatory Acne), by Formulation (Topical Medications and Oral Medications), by Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others), and by Distribution Channel (Med Spa, Aesthetician, Dermatologist, and Other Professional Channels) – Opportunity Analysis and Industry Forecast, 2024–2030

Asia-Pacific Professional Acne Medication Market

Industry:  Consumer Goods | Publish Date: Feb 2024 | No of Pages:  159 | No. Tables:  110 | No. Figures:  75

Market Definition

Asia-Pacific Professional Acne Medication Market was valued at USD 713.25 million in 2023 and is predicted to reach USD 1445.50 million by 2030, with a CAGR of 10.6% from 2024 to 2030. The professional acne medicine market refers to dermatologist-prescribed specialist skincare formulations for focused and effective acne therapy, treating both inflammatory and non-inflammatory lesions while reducing scarring. These formulations provide benefits such as powerful and customized chemicals, frequently outperforming over-the-counter alternatives. 

Professional acne treatments, which are widely used in dermatological services, cater to those who have severe or persistent acne problems, assuring a better degree of efficacy and control. As the demand for advanced skincare grows, this industry will remain critical in delivering tailored and medically guided ways to cleaner, healthier skin.

Rising Demand for Non-Invasive Cosmetic Treatments Driving the Market

The professional acne medication market in the Asia-Pacific region is witnessing substantial growth, primarily fuelled by the increasing demand for non-invasive cosmetic treatments designed specifically for treating acne. A recent market expansion was exemplified by Crown Aesthetics, a division of Crown Laboratories, Inc., which expanded into the Asia-Pacific region. Crown Laboratories introduces its award-winning and first FDA-cleared micro needling system, SkinPen Precision, and the unique living probiotic, BIOJUVE, demonstrating the region's increasing receptiveness to innovative and non-invasive acne treatment solutions.

 

Expansion of Infrastructure and Technology Fuelling the Growth of the Market

The expansion of healthcare infrastructure, the increasing fixed base of medical equipment, and the growing penetration of new technologies are fundamental drivers behind the robust growth of the professional acne medication market in the Asia-Pacific region. Additionally, the Asia-Pacific region boasts a rich culture of wellness and self-care practices, significantly contributing to the development and popularity of medical spas that offer effective solutions for acne-related concerns. This cultural inclination towards self-care and holistic well-being plays a pivotal role in propelling the professional acne medication market, aligning with the evolving preferences of consumers in the region.

 

Strict Regulation Hindering Professional Acne Medication Market Growth

One of the significant restraining factors for the professional acne medication market in the Asia-Pacific region is the presence of stringent regulations and varying compliance standards across countries. The diverse regulatory landscape makes it difficult for companies to navigate and ensure compliance, affecting the ease of conducting business and providing services in different countries. This, in turn, hampers the market's growth potential by increasing the complexities and costs associated with meeting regulatory requirements across the region.

Data-Driven Healthcare is Creating Growth Opportunities for the Market

The Asia-Pacific professional acne medication market is poised to tap into the transformative power of big data and advanced analytics, presenting a compelling opportunity for personalized treatment recommendations and monitoring. This data-driven paradigm offers an exciting pathway to enhance treatment outcomes, heighten patient satisfaction, and fuel market growth.By harnessing the capabilities of comprehensive data analysis, healthcare providers in the Asia-Pacific region can fine-tune acne treatments with exceptional precision. This tailored approach takes into account a spectrum of individual factors, including skin type, genetic predispositions, and treatment response, thereby optimizing the effectiveness of professional acne care. 

China Holds the Dominant Share in the Market

Technological Innovations are a primary driving force behind the growth of the professional acne medication market in China. Continuous advancements in dermatological technologies, particularly in the fields of laser therapies and microdermabrasion, are revolutionizing acne treatment options. The appeal of the advanced technologies lies in their ability to provide quicker results with minimal disruption to patients' daily lives, making them increasingly popular and contributing to the market's expansion. According to the Chinese Medical Association Publishing House, recent developments in artificial intelligence (AI) and skin imaging technology have improved dermatological AI applications. The Chinese Skin Image Database (CSID) addressed data challenges, fostering pioneering achievements in AI-assisted dermatology.

Additionally, the growing emphasis on personal appearance and overall well-being is a key driver behind the expanding Professional Acne Medication Market in China. Individuals are increasingly seeking out these treatments to address their aesthetic concerns and achieve skin that is not only blemish-free but also radiant and healthy. This cultural shift towards prioritizing one's appearance and wellness aligns with the evolving preferences of consumers in China, making professional acne treatments more popular and contributing to the market's growth.

India is Expected to Show Steady Growth in the Asia-Pacific Market

In India, the growth of the Professional Acne Medication Market is significantly influenced by government initiatives. Regulatory developments in the healthcare sector have been pivotal in driving market expansion. These initiatives aim to encourage commercial insurance coverage for a wide range of healthcare services, including professional acne treatments. Evolving healthcare policies further contribute to a favourable environment for the market, aligning with the government's goal of improving healthcare accessibility and affordability for the population.

Moreover, the youthful population in India plays a pivotal role in driving the growth of the Professional Acne Medication Market. India has a demographic profile with a significant proportion of adolescents and young adults. This demographic segment is particularly prone to acne-related skin issues due to factors such as hormonal changes and lifestyle stressors. As a result, there is a consistent and substantial demand for professional acne treatments. This high prevalence of acne in the youthful population ensures a steady and sustained demand for professional acne treatments, making it a key driver for market growth in India.

 

Competitive Landscape

The Asia-Pacific professional acne medication industry includes several market players such as Almirall SA, Bausch Health Companies, Inc., GlaxoSmithKline Plc (GSK), Galderma SA, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, STRATA Skin Sciences, Inc., Mayne Pharma Group Limited, and Pfizer, Inc., and others.

Asia-Pacific Professional Acne Medication Market Key Segments

By Acne Type    

  • Inflammatory Acne 

  • Non-inflammatory Acne 

By Formulation    

  • Topical Medications

  • Oral Medications 

By Therapeutic Class

  • Retinoids

  • Antibiotics

  • Salicylic Acid

  • Benzoyl Peroxide

  • Others

By Distribution Channel

  • Med Spa

  • Aesthetician

  • Dermatologist

  • Other Professional Channels

By Geography

  • Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Taiwan

    • Vietnam 

    • Rest of Asia-Pacific

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Market Size in 2023

USD 713.25 Million

Revenue Forecast in 2030

USD 1445.50 Million

Growth Rate

CAGR of 10.6% from 2024 to 2030

Analysis Period

2023–2030

Base Year Considered

2023

Forecast Period

2024–2030

Market Size Estimation

Million (USD)

Growth Factors

Rising demand for non-invasive cosmetic treatments.

Expansion in infrastructure and technology.

Countries Covered

7

Companies Profiled

10

Market Share

Available for 10 companies

Customization Scope

Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs.

Test

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6      ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET BY ACNE TYPE

           6.1      OVERVIEW

           6.2      INFLAMMATORY ACNE

                         6.2.1      INFLAMMATORY ACNE MARKET, BY COUNTRY

           6.3      NON-INFLAMMATORY ACNE

                         6.3.1      NON-INFLAMMATORY ACNE MARKET, BY COUNTRY

7      ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET BY FORMULATION

           7.1      OVERVIEW

           7.2      TOPICAL MEDICATIONS

                         7.2.1      TOPICAL MEDICATIONS MARKET, BY COUNTRY

           7.3      ORAL MEDICATIONS

                         7.3.1      ORAL MEDICATIONS MARKET, BY COUNTRY

8      ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET BY THERAPEUTIC CLASS

           8.1      OVERVIEW

           8.2      RETINOIDS

                         8.2.1      RETINOIDS MARKET, BY COUNTRY

           8.3      ANTIBIOTICS

                         8.3.1      ANTIBIOTICS MARKET, BY COUNTRY

           8.4      SALICYLIC ACID

                         8.4.1      SALICYLIC ACID MARKET, BY COUNTRY

           8.5      BENZOYL PEROXIDE

                         8.5.1      BENZOYL PEROXIDE MARKET, BY COUNTRY

           8.6      OTHERS

                         8.6.1      OTHERS MARKET, BY COUNTRY

9      ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET BY DISTRIBUTION CHANNEL

           9.1      OVERVIEW

           9.2      MED SPA

                         9.2.1      MED SPA MARKET, BY COUNTRY

           9.3      AESTHETICIAN

                         9.3.1      AESTHETICIAN MARKET, BY COUNTRY

           9.4      DERMATOLOGIST

                         9.4.1      DERMATOLOGIST MARKET, BY COUNTRY

           9.5      OTHER PROFESSIONAL CHANNELS

                         9.5.1      OTHER PROFESSIONAL CHANNELS MARKET, BY COUNTRY

10   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY COUNTRY

           10.1   OVERVIEW

           10.2   AUSTRALIA

                         10.2.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.2.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.2.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.2.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.3   CHINA

                         10.3.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.3.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.3.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.3.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.4   INDIA

                         10.4.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.4.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.4.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.4.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.5   JAPAN

                         10.5.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.5.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.5.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.5.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.6   SOUTH KOREA

                         10.6.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.6.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.6.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.6.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.7   TAIWAN

                         10.7.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.7.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.7.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.7.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.8   VIETNAM

                         10.8.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.8.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.8.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.8.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

           10.9   REST OF ASIA-PACIFIC

                         10.9.1   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY ACNE TYPE

                         10.9.2   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY FORMULATION

                         10.9.3   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS

                         10.9.4   ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL

11   COMPANY PROFILES

           11.1   BAYER AG

                         11.1.1   COMPANY OVERVIEW

                         11.1.2   COMPANY SNAPSHOT

                         11.1.3   OPERATING BUSINESS SEGMENTS

                         11.1.4   PRODUCT PORTFOLIO

                         11.1.5   BUSINESS PERFORMANCE

                         11.1.6   BUSINESS SEGMENTS

                         11.1.7   GEOGRAPHIC SEGMENTS

                         11.1.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.1.9   PRIMARY MARKET COMPETITORS

           11.2   NESTLE S.A.

                         11.2.1   COMPANY OVERVIEW

                         11.2.2   COMPANY SNAPSHOT

                         11.2.3   OPERATING BUSINESS SEGMENTS

                         11.2.4   PRODUCT PORTFOLIO

                         11.2.5   BUSINESS PERFORMANCE

                         11.2.6   BUSINESS SEGMENTS

                         11.2.7   GEOGRAPHIC SEGMENTS

                         11.2.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.2.9   PRIMARY MARKET COMPETITORS

           11.3   PFIZER INC.

                         11.3.1   COMPANY OVERVIEW

                         11.3.2   COMPANY SNAPSHOT

                         11.3.3   OPERATING BUSINESS SEGMENTS

                         11.3.4   PRODUCT PORTFOLIO

                         11.3.5   BUSINESS PERFORMANCE

                         11.3.6   BUSINESS SEGMENTS

                         11.3.7   GEOGRAPHIC SEGMENTS

                         11.3.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.3.9   PRIMARY MARKET COMPETITORS

           11.4   JOHNSON AND JOHNSON

                         11.4.1   COMPANY OVERVIEW

                         11.4.2   COMPANY SNAPSHOT

                         11.4.3   OPERATING BUSINESS SEGMENTS

                         11.4.4   PRODUCT PORTFOLIO

                         11.4.5   BUSINESS PERFORMANCE

                         11.4.6   BUSINESS SEGMENTS

                         11.4.7   GEOGRAPHIC SEGMENTS

                         11.4.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.4.9   PRIMARY MARKET COMPETITORS

           11.5   ROCHE HOLDING AG

                         11.5.1   COMPANY OVERVIEW

                         11.5.2   COMPANY SNAPSHOT

                         11.5.3   OPERATING BUSINESS SEGMENTS

                         11.5.4   PRODUCT PORTFOLIO

                         11.5.5   BUSINESS PERFORMANCE

                         11.5.6   BUSINESS SEGMENTS

                         11.5.7   GEOGRAPHIC SEGMENTS

                         11.5.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.5.9   PRIMARY MARKET COMPETITORS

           11.6   GLAXOSMITHKLINE PLC

                         11.6.1   COMPANY OVERVIEW

                         11.6.2   COMPANY SNAPSHOT

                         11.6.3   OPERATING BUSINESS SEGMENTS

                         11.6.4   PRODUCT PORTFOLIO

                         11.6.5   BUSINESS PERFORMANCE

                         11.6.6   BUSINESS SEGMENTS

                         11.6.7   GEOGRAPHIC SEGMENTS

                         11.6.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.6.9   PRIMARY MARKET COMPETITORS

           11.7   GALDERMA S.A.

                         11.7.1   COMPANY OVERVIEW

                         11.7.2   COMPANY SNAPSHOT

                         11.7.3   OPERATING BUSINESS SEGMENTS

                         11.7.4   PRODUCT PORTFOLIO

                         11.7.5   BUSINESS PERFORMANCE

                         11.7.6   BUSINESS SEGMENTS

                         11.7.7   GEOGRAPHIC SEGMENTS

                         11.7.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.7.9   PRIMARY MARKET COMPETITORS

           11.8   ALLERGAN PLC

                         11.8.1   COMPANY OVERVIEW

                         11.8.2   COMPANY SNAPSHOT

                         11.8.3   OPERATING BUSINESS SEGMENTS

                         11.8.4   PRODUCT PORTFOLIO

                         11.8.5   BUSINESS PERFORMANCE

                         11.8.6   BUSINESS SEGMENTS

                         11.8.7   GEOGRAPHIC SEGMENTS

                         11.8.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.8.9   PRIMARY MARKET COMPETITORS

           11.9   STIEFEL LABORATORIES INC.

                         11.9.1   COMPANY OVERVIEW

                         11.9.2   COMPANY SNAPSHOT

                         11.9.3   OPERATING BUSINESS SEGMENTS

                         11.9.4   PRODUCT PORTFOLIO

                         11.9.5   BUSINESS PERFORMANCE

                         11.9.6   BUSINESS SEGMENTS

                         11.9.7   GEOGRAPHIC SEGMENTS

                         11.9.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.9.9   PRIMARY MARKET COMPETITORS

           11.10   BAUSCH HEALTH COMPANIES INC.

                         11.10.1   COMPANY OVERVIEW

                         11.10.2   COMPANY SNAPSHOT

                         11.10.3   OPERATING BUSINESS SEGMENTS

                         11.10.4   PRODUCT PORTFOLIO

                         11.10.5   BUSINESS PERFORMANCE

                         11.10.6   BUSINESS SEGMENTS

                         11.10.7   GEOGRAPHIC SEGMENTS

                         11.10.8   KEY STRATEGIC MOVES AND DEVELOPMENT

                         11.10.9   PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 2. INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 3. NON-INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 4. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 5. TOPICAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 6. ORAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 7. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 8. RETINOIDS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 9. ANTIBIOTICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 10. SALICYLIC ACID, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 11. BENZOYL PEROXIDE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 12. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 13. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 14. MED SPA, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 15. AESTHETICIAN, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 16. DERMATOLOGIST, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 17. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 18. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

TABLE 19. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 20. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 21. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 22. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 23. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 24. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 25. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 26. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 27. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 28. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 29. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 30. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 31. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 32. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 33. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 34. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 35. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 36. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 37. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 38. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 39. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 40. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 41. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 42. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 43. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 44. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 45. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 46. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 47. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

TABLE 48. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

TABLE 49. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

TABLE 50. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

TABLE 51. BAYER AG: COMPANY SNAPSHOT

TABLE 52. BAYER AG: OPERATING BUSINESS SEGMENTS

TABLE 53. BAYER AG: PRODUCT PORTFOLIO

TABLE 54. BAYER AG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 55. BAYER AG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 56. BAYER AG: KEY STRATERGY

TABLE 57. NESTLE S.A.: COMPANY SNAPSHOT

TABLE 58. NESTLE S.A.: OPERATING BUSINESS SEGMENTS

TABLE 59. NESTLE S.A.: PRODUCT PORTFOLIO

TABLE 60. NESTLE S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 61. NESTLE S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 62. NESTLE S.A.: KEY STRATERGY

TABLE 63. PFIZER INC.: COMPANY SNAPSHOT

TABLE 64. PFIZER INC.: OPERATING BUSINESS SEGMENTS

TABLE 65. PFIZER INC.: PRODUCT PORTFOLIO

TABLE 66. PFIZER INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 67. PFIZER INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 68. PFIZER INC.: KEY STRATERGY

TABLE 69. JOHNSON AND JOHNSON: COMPANY SNAPSHOT

TABLE 70. JOHNSON AND JOHNSON: OPERATING BUSINESS SEGMENTS

TABLE 71. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO

TABLE 72. JOHNSON AND JOHNSON: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 73. JOHNSON AND JOHNSON: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 74. JOHNSON AND JOHNSON: KEY STRATERGY

TABLE 75. ROCHE HOLDING AG: COMPANY SNAPSHOT

TABLE 76. ROCHE HOLDING AG: OPERATING BUSINESS SEGMENTS

TABLE 77. ROCHE HOLDING AG: PRODUCT PORTFOLIO

TABLE 78. ROCHE HOLDING AG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 79. ROCHE HOLDING AG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 80. ROCHE HOLDING AG: KEY STRATERGY

TABLE 81. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT

TABLE 82. GLAXOSMITHKLINE PLC: OPERATING BUSINESS SEGMENTS

TABLE 83. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO

TABLE 84. GLAXOSMITHKLINE PLC: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 85. GLAXOSMITHKLINE PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 86. GLAXOSMITHKLINE PLC: KEY STRATERGY

TABLE 87. GALDERMA S.A.: COMPANY SNAPSHOT

TABLE 88. GALDERMA S.A.: OPERATING BUSINESS SEGMENTS

TABLE 89. GALDERMA S.A.: PRODUCT PORTFOLIO

TABLE 90. GALDERMA S.A.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 91. GALDERMA S.A.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 92. GALDERMA S.A.: KEY STRATERGY

TABLE 93. ALLERGAN PLC: COMPANY SNAPSHOT

TABLE 94. ALLERGAN PLC: OPERATING BUSINESS SEGMENTS

TABLE 95. ALLERGAN PLC: PRODUCT PORTFOLIO

TABLE 96. ALLERGAN PLC: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 97. ALLERGAN PLC: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 98. ALLERGAN PLC: KEY STRATERGY

TABLE 99. STIEFEL LABORATORIES INC.: COMPANY SNAPSHOT

TABLE 100. STIEFEL LABORATORIES INC.: OPERATING BUSINESS SEGMENTS

TABLE 101. STIEFEL LABORATORIES INC.: PRODUCT PORTFOLIO

TABLE 102. STIEFEL LABORATORIES INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 103. STIEFEL LABORATORIES INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 104. STIEFEL LABORATORIES INC.: KEY STRATERGY

TABLE 105. BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT

TABLE 106. BAUSCH HEALTH COMPANIES INC.: OPERATING BUSINESS SEGMENTS

TABLE 107. BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO

TABLE 108. BAUSCH HEALTH COMPANIES INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 109. BAUSCH HEALTH COMPANIES INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 110. BAUSCH HEALTH COMPANIES INC.: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE, 2023-2030, (MILLION USD)

FIGURE 7. INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 8. NON-INFLAMMATORY ACNE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 9. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION, 2023-2030, (MILLION USD)

FIGURE 10. TOPICAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 11. ORAL MEDICATIONS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 12. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS, 2023-2030, (MILLION USD)

FIGURE 13. RETINOIDS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 14. ANTIBIOTICS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 15. SALICYLIC ACID, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 16. BENZOYL PEROXIDE, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 17. OTHERS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 18. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, (MILLION USD)

FIGURE 19. MED SPA, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 20. AESTHETICIAN, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 21. DERMATOLOGIST, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 22. OTHER PROFESSIONAL CHANNELS, MARKET VALUE, BY COUNTRY, 2023-2030, (MILLION USD)

FIGURE 23. ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY REGION 2023-2030, (MILLION USD)

FIGURE 24. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 25. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 26. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 27. AUSTRALIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 28. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 29. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 30. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 31. CHINA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 32. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 33. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 34. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 35. INDIA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 36. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 37. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 38. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 39. JAPAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 40. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 41. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 42. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 43. SOUTH KOREA ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 44. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 45. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 46. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 47. TAIWAN ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 48. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 49. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 50. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 51. VIETNAM ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 52. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY ACNE TYPE 2023-2030, (MILLION USD)

FIGURE 53. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY FORMULATION 2023-2030, (MILLION USD)

FIGURE 54. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY THERAPEUTIC CLASS 2023-2030, (MILLION USD)

FIGURE 55. REST OF ASIA-PACIFIC PROFESSIONAL ACNE MEDICATION MARKET VALUE, BY DISTRIBUTION CHANNEL 2023-2030, (MILLION USD)

FIGURE 56. BAYER AG: NET SALES, (2021-2023)

FIGURE 57. BAYER AG: PRIMARY MARKET COMPETITORS

FIGURE 58. NESTLE S.A.: NET SALES, (2021-2023)

FIGURE 59. NESTLE S.A.: PRIMARY MARKET COMPETITORS

FIGURE 60. PFIZER INC.: NET SALES, (2021-2023)

FIGURE 61. PFIZER INC.: PRIMARY MARKET COMPETITORS

FIGURE 62. JOHNSON AND JOHNSON: NET SALES, (2021-2023)

FIGURE 63. JOHNSON AND JOHNSON: PRIMARY MARKET COMPETITORS

FIGURE 64. ROCHE HOLDING AG: NET SALES, (2021-2023)

FIGURE 65. ROCHE HOLDING AG: PRIMARY MARKET COMPETITORS

FIGURE 66. GLAXOSMITHKLINE PLC: NET SALES, (2021-2023)

FIGURE 67. GLAXOSMITHKLINE PLC: PRIMARY MARKET COMPETITORS

FIGURE 68. GALDERMA S.A.: NET SALES, (2021-2023)

FIGURE 69. GALDERMA S.A.: PRIMARY MARKET COMPETITORS

FIGURE 70. ALLERGAN PLC: NET SALES, (2021-2023)

FIGURE 71. ALLERGAN PLC: PRIMARY MARKET COMPETITORS

FIGURE 72. STIEFEL LABORATORIES INC.: NET SALES, (2021-2023)

FIGURE 73. STIEFEL LABORATORIES INC.: PRIMARY MARKET COMPETITORS

FIGURE 74. BAUSCH HEALTH COMPANIES INC.: NET SALES, (2021-2023)

FIGURE 75. BAUSCH HEALTH COMPANIES INC.: PRIMARY MARKET COMPETITORS

KEY PLAYERS

  • Bayer AG

  • Nestle S.A.

  • Pfizer Inc.

  • Johnson & Johnson

  • Roche Holding AG

  • GlaxoSmithKline plc

  • Galderma S.A.

  • Allergan plc

  • Stiefel Laboratories Inc.

  • Bausch Health Companies Inc.


Frequently Asked Questions
What will be the worth of the Asia-Pacific Professional acne medication market by the end of 2030?

According to the report published by Next Move Consulting, the Asia-Pacific professional acne medication market business is expected to hit at USD 713.25 million by 2030.

What are the leading companies in the Asia-Pacific professional acne medication market?

The Asia-Pacific professional acne medication industry includes several market players such as Bayer AG, Nestle S.A., Pfizer Inc., Johnson & Johnson, Roche Holding AG, and others.

What are the market segmentations and scope of the study for the Asia-Pacific professional acne medication industry?

The Asia-Pacific Professional acne medication market share is segmented based on acne type, formulation, therapeutic class, distribution channel, and geography.

What are the factors that are driving the growth of the professional acne medication market in Asia-Pacific?

The growth of the professional acne medication market in Asia-Pacific is primarily driven by the rising demand for non-invasive cosmetic treatments, and infrastructure and technology expansion.

What is restraining the growth of the Asia-Pacific professional acne medication market?

The presence of stringent regulations and varying compliance standards across countries presents a substantial restraint on the market's growth in Asia-Pacific.